BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PPARA
,
G-protein-coupled receptor binding
,
Arthritis
,
Retina
,
Nosology
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
LAG3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
T Lymphocyte (CD8+) of peripheral blood
Natural killer cell of peripheral blood
T Lymphocyte (regulatory) of peripheral blood
Appendix
T Lymphocyte (CD4+) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
LAG3 in gastric cancer: it's complicated.
Research progress of immune heckpoint LAG-3 in gastric cancer: a narrative review.
From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmu…
Understanding LAG-3 Signaling.
Overexpression of LAG3, TIM3, and A2aR in adenoid cystic carcinoma and mucoepidermoid carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint In…
LAG3 PET Imaging in Advanced Solid Tumors
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic …
Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanom…
Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ